141 related articles for article (PubMed ID: 14672820)
21. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
[TBL] [Abstract][Full Text] [Related]
22. Effect of levodopa on electroencephalographic biomarkers of the parkinsonian state.
Miller AM; Miocinovic S; Swann NC; Rajagopalan SS; Darevsky DM; Gilron R; de Hemptinne C; Ostrem JL; Starr PA
J Neurophysiol; 2019 Jul; 122(1):290-299. PubMed ID: 31066605
[TBL] [Abstract][Full Text] [Related]
23. Electroencephalographic lateralization, clinical correlates and pharmacological response in untreated Parkinson's disease.
Mostile G; Nicoletti A; Dibilio V; Luca A; Pappalardo I; Giuliano L; Cicero CE; Sciacca G; Raciti L; Contrafatto D; Bruno E; Sofia V; Zappia M
Parkinsonism Relat Disord; 2015 Aug; 21(8):948-53. PubMed ID: 26096796
[TBL] [Abstract][Full Text] [Related]
24. The effects of handedness and type of movement on the contralateral preponderance of mu-rhythm desynchronisation.
Stancák A; Pfurtscheller G
Electroencephalogr Clin Neurophysiol; 1996 Aug; 99(2):174-82. PubMed ID: 8761053
[TBL] [Abstract][Full Text] [Related]
25. Chronic administration of L-dopa affects the movement-related cortical potentials of patients with Parkinson's disease.
Feve AP; Bathien N; Rondot P
Clin Neuropharmacol; 1992 Apr; 15(2):100-8. PubMed ID: 1591735
[TBL] [Abstract][Full Text] [Related]
26. Motor preparation is more impaired in Parkinson's disease when sensorimotor integration is involved.
Labyt E; Devos D; Bourriez JL; Cassim F; Destée A; Guieu JD; Defebvre L; Derambure P
Clin Neurophysiol; 2003 Dec; 114(12):2423-33. PubMed ID: 14652103
[TBL] [Abstract][Full Text] [Related]
27. theta, beta But not alpha-band EEG connectivity has implications for dual task performance in Parkinson's disease.
Palmer SJ; Lee PW; Wang ZJ; Au WL; McKeown MJ
Parkinsonism Relat Disord; 2010 Jul; 16(6):393-7. PubMed ID: 20435504
[TBL] [Abstract][Full Text] [Related]
28. The effect of Parkinson's disease and levodopa on adaptation of anticipatory postural adjustments.
Hall LM; Brauer SG; Horak F; Hodges PW
Neuroscience; 2013 Oct; 250():483-92. PubMed ID: 23867768
[TBL] [Abstract][Full Text] [Related]
29. Bad oscillations in Parkinson's disease.
Brown P
J Neural Transm Suppl; 2006; (70):27-30. PubMed ID: 17017505
[TBL] [Abstract][Full Text] [Related]
30. Altered directional connectivity in Parkinson's disease during performance of a visually guided task.
Tropini G; Chiang J; Wang ZJ; Ty E; McKeown MJ
Neuroimage; 2011 Jun; 56(4):2144-56. PubMed ID: 21402160
[TBL] [Abstract][Full Text] [Related]
31. Attenuated beta rebound to proprioceptive afferent feedback in Parkinson's disease.
Vinding MC; Tsitsi P; Piitulainen H; Waldthaler J; Jousmäki V; Ingvar M; Svenningsson P; Lundqvist D
Sci Rep; 2019 Feb; 9(1):2604. PubMed ID: 30796340
[TBL] [Abstract][Full Text] [Related]
32. Motivational Vigor in Parkinson's Disease Requires the Short and Long Duration Response to Levodopa.
Brissenden JA; Scerbak T; Albin RL; Lee TG
Mov Disord; 2024 Jan; 39(1):76-84. PubMed ID: 38062630
[TBL] [Abstract][Full Text] [Related]
33. Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease.
Devos D; Lejeune S; Cormier-Dequaire F; Tahiri K; Charbonnier-Beaupel F; Rouaix N; Duhamel A; Sablonnière B; Bonnet AM; Bonnet C; Zahr N; Costentin J; Vidailhet M; Corvol JC
Parkinsonism Relat Disord; 2014 Feb; 20(2):170-5. PubMed ID: 24216088
[TBL] [Abstract][Full Text] [Related]
34. Event-related desynchronization to contingent negative variation and self-paced movement paradigms in Parkinson's disease.
Magnani G; Cursi M; Leocani L; Volonté MA; Locatelli T; Elia A; Comi G
Mov Disord; 1998 Jul; 13(4):653-60. PubMed ID: 9686770
[TBL] [Abstract][Full Text] [Related]
35. Influence of white matter MRI hyper-intensities on acute l-dopa response in patients with Parkinson's disease.
Arena JE; Cerquetti D; Rossi M; Chaves H; Rollan C; Dossi DE; Merello M
Parkinsonism Relat Disord; 2016 Mar; 24():126-8. PubMed ID: 26823237
[TBL] [Abstract][Full Text] [Related]
36. Re-emergent Tremor in Parkinson's Disease: Evidence of Pathologic β and Prokinetic γ Activity.
Ding H; Nasseroleslami B; Mirzac D; Isaias IU; Volkmann J; Deuschl G; Groppa S; Muthuraman M
Mov Disord; 2024 May; 39(5):778-787. PubMed ID: 38532269
[TBL] [Abstract][Full Text] [Related]
37. Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.
Merello M; Gerschcovich ER; Ballesteros D; Cerquetti D
Parkinsonism Relat Disord; 2011 Nov; 17(9):705-7. PubMed ID: 21784692
[TBL] [Abstract][Full Text] [Related]
38. Differential modulation of STN-cortical and cortico-muscular coherence by movement and levodopa in Parkinson's disease.
Hirschmann J; Özkurt TE; Butz M; Homburger M; Elben S; Hartmann CJ; Vesper J; Wojtecki L; Schnitzler A
Neuroimage; 2013 Mar; 68():203-13. PubMed ID: 23247184
[TBL] [Abstract][Full Text] [Related]
39. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
Pawlukowska W; Gołąb-Janowska M; Safranow K; Rotter I; Amernik K; Honczarenko K; Nowacki P
Neurol Neurochir Pol; 2015; 49(5):302-6. PubMed ID: 26377981
[TBL] [Abstract][Full Text] [Related]
40. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
